Results 241 to 250 of about 1,610,430 (355)

Identification and Characterization of eccDNA in HepG2 Cells Under DOX-Induced DNA Damage. [PDF]

open access: yesInt J Mol Sci
Zhang J   +8 more
europepmc   +1 more source

An oxidative DNA “damage” and repair mechanism localized in the VEGF promoter is important for hypoxia-induced VEGF mRNA expression [PDF]

open access: bronze, 2015
Viktor Pastukh   +7 more
openalex   +1 more source

Olink Proteomics Analysis Reveals Heterogeneous Responses to FcRn Blockade in Anti‐AChR Antibody‐Positive Myasthenia Gravis: FGF‐19 as a Novel Biomarker

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective This study aimed to systematically observe the clinical manifestations, immune cell subsets, and dynamic changes in serological indicators in patients with myasthenia gravis (MG) before and after efgartigimod (EFG) treatment. Methods We analyzed the baseline data, laboratory parameters, and lymphocyte subset proportions in MG ...
Tiancheng Luo   +9 more
wiley   +1 more source

The role of lncRNA SNHG15 in UV-induced DNA damage repair. [PDF]

open access: yesPLoS One
Zhang X   +7 more
europepmc   +1 more source

Elevated DNA damage without signs of aging in the short-sleeping Mexican cavefish. [PDF]

open access: yesElife
Lloyd E   +13 more
europepmc   +1 more source

Reduction in Renal Relapse and Preservation of Long‐Term Kidney Function After Lupus Low Disease Activity in Patients With Lupus Nephritis

open access: yesArthritis Care &Research, EarlyView.
Objective Lupus low disease activity state (LLDAS) is a validated treatment target in systemic lupus erythematosus (SLE), but limited studies have explored the role of LLDAS in lupus nephritis (LN). This study aims to investigate the frequency and predictors of LLDAS attainment and its benefit on LN relapse and renal function preservation in patients ...
Chak Kwan Cheung   +6 more
wiley   +1 more source

RBM39 Contributes to MGMT Maintenance in Response to Temozolomide-Induced DNA Damage. [PDF]

open access: yesCancers (Basel)
Khalaj V   +7 more
europepmc   +1 more source

Prevalence, determinants and outcomes of low disease activity and remission attainment in SLE patients with clinically active disease

open access: yesArthritis Care &Research, Accepted Article.
Objectives This study aimed to identify the frequency and determinants of Lupus Low Disease Activity State (LLDAS) and Definition of Remission in SLE (DORIS‐remission) attainment in systemic lupus erythematosus (SLE) patients with clinically active disease, and the frequency and determinants of flare and damage accrual after target attainment.
Yanjie Hao   +39 more
wiley   +1 more source

ATR, a DNA damage kinase, modulates DNA replication timing in Leishmania major. [PDF]

open access: yesPLoS Genet
da Silva GLA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy